Biomerica, Inc. (BMRA)
2.57
-0.11
(-4.10%)
USD |
NASDAQ |
Jan 16, 16:00
2.615
+0.04
(+1.75%)
Pre-Market: 20:00
Biomerica Profit Margin (Quarterly): -109.1% for Nov. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -12.43K% |
| InfuSystem Holdings, Inc. | 6.19% |
| Xtant Medical Holdings, Inc. | 3.93% |
| VolitionRX Ltd. | -862.4% |
| Catheter Precision, Inc. | -1.04K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -82.67% |
| Return on Assets | -60.11% |
| Return on Invested Capital | -75.58% |
| Gross Profit Margin (Quarterly) | 4.21% |
| Operating Margin (Quarterly) | -113.5% |
| Return on Net Operating Assets | -108.0% |